Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 … P Woo, N Wilkinson, AM Prieur, T Southwood, V Leone, P Livermore, ... Arthritis research & therapy 7 (6), R1281, 2005 | 312 | 2005 |
Harper's Textbook of pediatric dermatology AD Irvine, PH Hoeger, AC Yan John Wiley & Sons, 2011 | 131* | 2011 |
British Society for Rheumatology guideline on management of paediatric, adolescent and adult patients with idiopathic inflammatory myopathy AGS Oldroyd, JB Lilleker, T Amin, O Aragon, K Bechman, V Cuthbert, ... Rheumatology, 2022 | 73 | 2022 |
Anti‐tumour necrosis factor therapy associated with cutaneous vasculitis PA Livermore, KJ Murray Rheumatology 41 (12), 1450-1452, 2002 | 55 | 2002 |
Autologous T cell depleted haematopoietic stem cell transplantation in children with severe juvenile idiopathic arthritis in the UK (2000–2007) M Abinun, TJ Flood, AJ Cant, P Veys, AR Gennery, HE Foster, M Friswell, ... Molecular immunology 47 (1), 46-51, 2009 | 52 | 2009 |
Juvenile dermatomyositis. Where are we now? LJ McCann, P Livermore, MGL Wilkinson, LR Wedderburn Clin Exp Rheumatol 40, 394-403, 2022 | 42 | 2022 |
Being on the juvenile dermatomyositis rollercoaster: a qualitative study P Livermore, S Gray, K Mulligan, JN Stinson, LR Wedderburn, F Gibson Pediatric Rheumatology 17 (1), 30, 2019 | 35 | 2019 |
Teaching home administration of sub-cutaneous methotrexate P Livermore Paediatric Nursing 15 (3), 28, 2003 | 18 | 2003 |
The lived experience of juvenile idiopathic arthritis in young people receiving etanercept P Livermore, D Eleftheriou, LR Wedderburn Pediatric Rheumatology 14 (1), 21, 2016 | 14 | 2016 |
You give me a name that I can’t say, but I have to explain what it is every day: the power of poetry to share stories from young people with a rare disease P Livermore, LR Wedderburn, F Gibson Journal of Poetry Therapy 33 (1), 20-29, 2020 | 9 | 2020 |
Oxford handbook of musculoskeletal nursing SMO OBE Oxford University Press, 2020 | 7 | 2020 |
Development of a benchmarking toolkit for adolescent and young adult rheumatology services (BeTAR) RA Cai, H Chaplin, P Livermore, M Lee, D Sen, LR Wedderburn, ... Pediatric Rheumatology 17 (1), 1-11, 2019 | 7 | 2019 |
Assessing Psychosocial Needs in Juvenile Dermatomyositis Patients Across the United Kingdom P Livermore, L Wedderburn ARTHRITIS & RHEUMATOLOGY 71, 2019 | 7 | 2019 |
Mapping the current psychology provision for children and young people with juvenile dermatomyositis P Livermore, F Gibson, K Mulligan, LR Wedderburn, LJ McCann, S Gray Rheumatology Advances in Practice 5 (3), rkab062, 2021 | 6 | 2021 |
Juvenile idiopathic arthritis: updated guide to administering methotrexate P Livermore Nursing children and young people 26 (1), 2014 | 5 | 2014 |
A survey to understand the feelings towards and impact of COVID-19 on the households of juvenile dermato myositis patients from a parent or carer perspective MGL Wilkinson, W Wu, K O’Brien, CT Deakin, LR Wedderburn, ... Rheumatology advances in practice 5 (3), rkab058, 2021 | 3 | 2021 |
Administering Subcutaneous Methotrexate for Inflammatory Arthritis: RCN Guidance Royal College of Nursing RCN, 2016 | 2 | 2016 |
Experience of one UK site presenting a closer examination of safety and efficacy of Anakinra (Kineret®) in systemic juvenile idiopathic arthritis P Livermore, P Woo Pediatric Rheumatology 6 (S1), P32, 2008 | 2 | 2008 |
Towards a consensus for nurse education of methotrexate for people with rheumatic and musculoskeletal diseases: A scoping review A Marques, C Matos, E Nikiphorou, P Livermore, RJO Ferreira Musculoskeletal Care, 0 | 2 | |
OP0306-HPR POINTS TO CONSIDER FOR PATIENT EDUCATION PROVIDED BY NURSES ON METHOTREXATE USE. A EUROPEAN CONSENSUS INITIATIVE A Marques, P Livermore, U Martin, A Ludvigsen, K El Aoufy, C Matos, ... Annals of the Rheumatic Diseases 82 (Suppl 1), 198-199, 2023 | 1 | 2023 |